STOCK TITAN

[Form 4] NANO-X IMAGING LTD Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Daniel Ran, listed as the Chief Financial Officer of Nano-X Imaging Ltd. (NNOX), reported a direct purchase of ordinary shares on 09/05/2025. The Form 4 shows he acquired 1,000 ordinary shares at a price of $3.65 per share and, following the transaction, beneficially owned 6,950 ordinary shares in total. The filing indicates this is an individual filing by one reporting person and includes no derivative transactions.

Daniel Ran, indicato come Chief Financial Officer di Nano‑X Imaging Ltd. (NNOX), ha segnalato un acquisto diretto di azioni ordinarie in data 05/09/2025. Il Modulo 4 mostra che ha acquisito 1.000 azioni ordinarie al prezzo di $3,65 per azione e che, a seguito dell'operazione, deteneva beneficiariamente in totale 6.950 azioni ordinarie. La comunicazione precisa che si tratta di una segnalazione individuale da parte di un unico soggetto obbligato alla segnalazione e non include transazioni su strumenti derivati.

Daniel Ran, registrado como Director Financiero (CFO) de Nano‑X Imaging Ltd. (NNOX), informó una compra directa de acciones ordinarias el 05/09/2025. El Formulario 4 muestra que adquirió 1.000 acciones ordinarias a $3,65 por acción y que, tras la operación, poseía de forma beneficiaria un total de 6.950 acciones ordinarias. La presentación indica que se trata de una declaración individual de una sola persona informante y no incluye transacciones con derivados.

Daniel Ran은 Nano‑X Imaging Ltd. (NNOX)의 최고재무책임자(CFO)로 기재되어 있으며, 2025년 9월 5일 보통주를 직접 매수했다고 신고했습니다. Form 4에는 그가 주당 $3.65에 보통주 1,000주를 취득했으며, 거래 후 총 6,950주의 보통주를 실질적으로 보유하게 되었다고 기재되어 있습니다. 신고서에는 단일 보고자에 의한 개인 신고이며 파생상품 거래는 포함되어 있지 않다고 명시되어 있습니다.

Daniel Ran, inscrit en tant que directeur financier (CFO) de Nano‑X Imaging Ltd. (NNOX), a déclaré un achat direct d'actions ordinaires en date du 05/09/2025. Le formulaire 4 indique qu'il a acquis 1 000 actions ordinaires au prix de 3,65 $ par action et qu'à la suite de la transaction, il détenait bénéficiairement au total 6 950 actions ordinaires. Le dépôt précise qu'il s'agit d'une déclaration individuelle par une seule personne déclarante et qu'aucune transaction sur dérivés n'est incluse.

Daniel Ran, als Chief Financial Officer von Nano‑X Imaging Ltd. (NNOX) geführt, meldete am 05.09.2025 einen direkten Erwerb von Stammaktien. Das Formular 4 weist aus, dass er 1.000 Stammaktien zu einem Preis von $3,65 je Aktie erworben hat und nach der Transaktion insgesamt wirtschaftlich 6.950 Stammaktien besaß. Die Meldung gibt an, dass es sich um eine Einzelmeldung einer einzelnen meldepflichtigen Person handelt und keine Derivatgeschäfte enthält.

Positive
  • Insider acquisition recorded: Reporting person acquired 1,000 ordinary shares at $3.65 per share.
  • Clear post-transaction ownership: Reporting person beneficially owned 6,950 ordinary shares after the acquisition.
  • Complete Form 4 disclosure: Filing identifies reporting person, relationship (CFO), transaction details, and signature date.
Negative
  • None.

Insights

TL;DR: Routine insider purchase reported: 1,000 ordinary shares bought at $3.65, increasing direct holdings to 6,950 shares.

This Form 4 documents a straightforward non-derivative acquisition by the issuer's CFO, Daniel Ran, on 09/05/2025. The transaction is recorded as a direct purchase (code P) for 1,000 ordinary shares at $3.65, with no associated derivative instruments disclosed. For investors tracking insider activity, this entry is a factual record of ownership change rather than a material corporate event.

TL;DR: Governance disclosure: CFO filed a timely Form 4 showing a modest direct purchase and no complex arrangements.

The filing is concise and contains the required elements: reporting person identity and address, relationship to issuer (CFO), transaction date, transaction code, number of shares acquired, price, and post-transaction beneficial ownership. There are no amendments, no derivatives, and the report is signed and dated. This represents routine compliance with Section 16 reporting obligations.

Daniel Ran, indicato come Chief Financial Officer di Nano‑X Imaging Ltd. (NNOX), ha segnalato un acquisto diretto di azioni ordinarie in data 05/09/2025. Il Modulo 4 mostra che ha acquisito 1.000 azioni ordinarie al prezzo di $3,65 per azione e che, a seguito dell'operazione, deteneva beneficiariamente in totale 6.950 azioni ordinarie. La comunicazione precisa che si tratta di una segnalazione individuale da parte di un unico soggetto obbligato alla segnalazione e non include transazioni su strumenti derivati.

Daniel Ran, registrado como Director Financiero (CFO) de Nano‑X Imaging Ltd. (NNOX), informó una compra directa de acciones ordinarias el 05/09/2025. El Formulario 4 muestra que adquirió 1.000 acciones ordinarias a $3,65 por acción y que, tras la operación, poseía de forma beneficiaria un total de 6.950 acciones ordinarias. La presentación indica que se trata de una declaración individual de una sola persona informante y no incluye transacciones con derivados.

Daniel Ran은 Nano‑X Imaging Ltd. (NNOX)의 최고재무책임자(CFO)로 기재되어 있으며, 2025년 9월 5일 보통주를 직접 매수했다고 신고했습니다. Form 4에는 그가 주당 $3.65에 보통주 1,000주를 취득했으며, 거래 후 총 6,950주의 보통주를 실질적으로 보유하게 되었다고 기재되어 있습니다. 신고서에는 단일 보고자에 의한 개인 신고이며 파생상품 거래는 포함되어 있지 않다고 명시되어 있습니다.

Daniel Ran, inscrit en tant que directeur financier (CFO) de Nano‑X Imaging Ltd. (NNOX), a déclaré un achat direct d'actions ordinaires en date du 05/09/2025. Le formulaire 4 indique qu'il a acquis 1 000 actions ordinaires au prix de 3,65 $ par action et qu'à la suite de la transaction, il détenait bénéficiairement au total 6 950 actions ordinaires. Le dépôt précise qu'il s'agit d'une déclaration individuelle par une seule personne déclarante et qu'aucune transaction sur dérivés n'est incluse.

Daniel Ran, als Chief Financial Officer von Nano‑X Imaging Ltd. (NNOX) geführt, meldete am 05.09.2025 einen direkten Erwerb von Stammaktien. Das Formular 4 weist aus, dass er 1.000 Stammaktien zu einem Preis von $3,65 je Aktie erworben hat und nach der Transaktion insgesamt wirtschaftlich 6.950 Stammaktien besaß. Die Meldung gibt an, dass es sich um eine Einzelmeldung einer einzelnen meldepflichtigen Person handelt und keine Derivatgeschäfte enthält.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Daniel Ran

(Last) (First) (Middle)
104-20 QUEENS BLVD.
STE 15J

(Street)
FOREST HILLS NY 11375

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary shares 09/05/2025 P 1,000 A $3.65 6,950 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Ran Daniel 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Daniel Ran report on the Form 4 for NNOX?

The Form 4 reports a direct purchase of 1,000 ordinary shares of Nano-X Imaging Ltd. at $3.65 per share on 09/05/2025.

How many NNOX shares did the reporting person own after the transaction?

Following the reported purchase, the reporting person beneficially owned 6,950 ordinary shares.

What is the reporting person's role at Nano-X Imaging (NNOX)?

The Form 4 lists the reporting person, Daniel Ran, as an Officer with the title CFO.

Were any derivative securities reported in this Form 4 for NNOX?

No. The filing shows no derivative securities acquired, disposed of, or beneficially owned.

When was the Form 4 transaction dated and signed?

The transaction and the signature on the Form 4 are dated 09/05/2025.
Nano-X Imaging Ltd.

NASDAQ:NNOX

NNOX Rankings

NNOX Latest News

NNOX Latest SEC Filings

NNOX Stock Data

237.86M
63.79M
0.23%
20.83%
9.41%
Medical Devices
Healthcare
Link
Israel
Petah Tikva